To understand how to store peptides, start with the label on the medication in front of you. Reconstituted prescription vials are commonly labeled for refrigeration at 2–8 °C (36–46 °F), protected from light and never frozen. Lyophilized powder can have different limits. There is no universal shelf life after liquid is added: the pharmacy-printed beyond-use date controls. A timetable from a forum, another medication's carton or the date someone mixed a vial cannot replace that label.
How to store peptides: the pharmacy label is the rule
A compounded vial has a beyond-use date, or BUD, rather than a manufacturer expiration date. The BUD is the last date the specific preparation may be used under its stated storage conditions. It reflects the formulation, container, compounding process, sterility controls and available stability evidence.
That is why the BUD is not something a patient can derive by counting a standard number of days. USP <797> sets minimum standards for compounded sterile preparations; the dispensing pharmacy applies those standards and assigns the date for the preparation it made. The most reliable storage plan is simple: retain the original container, use the temperature and light conditions printed on it, and stop at its BUD even if liquid remains.
If the label is missing, smeared or unclear, the dispensing pharmacy needs to replace the instruction. Guessing is especially risky after a refrigerator failure or a package left in a hot vehicle because appearance alone cannot establish stability.
Lyophilized and reconstituted peptides are different
Lyophilization removes water and leaves a dry cake or powder. That solid state is often chosen because peptide and protein medicines can be less stable as liquids. It does not make the powder indestructible. A review of solid-state peptide and protein stability describes temperature, moisture, excipients and physical state as factors in deamidation, peptide-bond cleavage, oxidation and aggregation. The dry vial therefore follows its own label; refrigeration should not be assumed unless it is printed there.
Once a peptide is in solution, water enables additional chemical pathways. A 2023 review of therapeutic peptides in aqueous formulations describes hydrolysis, deamidation, oxidation and physical instability, with the rate depending on the individual peptide, pH, buffer and other formulation details. This is why “all reconstituted peptides last 28 days” is not a sound rule.
Sterility is a separate clock. Each puncture of a multi-use vial is an opportunity for contamination, and refrigeration does not reverse contamination that has occurred. In one 2023 hospital study, aerobic bacteria were recovered from 5.5% of opened multiple-dose vials and none of the single-dose vials sampled; handling environment, reused equipment and storage conditions were associated factors (Tabor et al., Infection Prevention in Practice). That study was not about peptide therapy, but it shows why a BUD accounts for more than chemical potency.
Reconstitution steps belong in the separate guide to how peptides are reconstituted. Storage begins with the finished pharmacy label, not with a homemade calculation.
Does sermorelin need to be refrigerated?
Reconstituted sermorelin is commonly labeled for storage at 2–8 °C, with protection from light and no freezing. Its pharmacy-printed BUD still determines how long that refrigerated vial may be used. An amber vial or outer container helps with light protection; it does not extend the date.
Dry sermorelin may arrive with different instructions, so the liquid rule should not be projected backward onto the lyophilized vial. Storage also does not answer clinical timing; that separate subject belongs to the sermorelin dosage guide.
BPC-157 makes the same point from the other direction. A compounded BPC-157 preparation may use a different concentration, diluent, container and BUD. Its label cannot be substituted for a sermorelin label, even when both arrive as refrigerated vials.
GLP-1 pens have their own room-temperature windows
Commercial pens are not governed by a generic peptide-storage rule. Their tested containers and formulations have product-specific instructions. Current U.S. prescribing information gives these examples:
| Product and device | Refrigerated storage | Defined room-temperature window |
|---|---|---|
| Ozempic multi-use pen | 2–8 °C before first use | After first use, 56 days at 15–30 °C or refrigerated; protect from excessive heat and sunlight |
| Wegovy single-use pen | 2–8 °C | Before cap removal, up to 28 days at 8–30 °C in the original carton |
| Zepbound single-dose pen or vial | 2–8 °C | Up to 21 days at no more than 30 °C; once kept at room temperature, the single-dose product is not returned to the refrigerator |
The device matters. The 2026 Zepbound label also gives separate 30-day conditions for its multi-dose vial and KwikPen. None of these windows transfers to a compounded semaglutide, tirzepatide or peptide vial. For pen technique rather than storage, see how to inject semaglutide.
What heat, freezing and travel change
Heat generally speeds chemical degradation. A short excursion does not reveal its own consequence, however: the temperature reached, time exposed, formulation and container all matter. The pharmacy can compare those facts with stability information for the specific preparation.
Freezing a liquid is not extra-cold refrigeration. Ice formation concentrates solutes into the remaining liquid and can change local pH, interfaces and particle formation. A 2026 study of physical stress in liquid peptide solutions found peptide- and container-specific changes under stirring, pumping, shaking and freeze-thaw conditions. A thawed vial can look normal and still fall outside its tested conditions. If a label says “do not freeze,” contact with a freezer wall or an unbuffered ice pack is not compliant storage.
For travel, an insulated medication pouch can maintain the labeled range without placing the vial directly against frozen material. Carry-on storage avoids the uncontrolled temperatures and separation risk of checked baggage. TSA's current screening rules allow medically necessary liquid medication, unused syringes accompanied by injectable medication and medically necessary gel packs in reasonable quantities. These items must be declared for inspection; a prescription label is recommended, though not federally required. Destination-country and airline rules may differ.
When the storage conditions break
Cloudiness, unexpected color, particles, a cracked vial or a loose stopper is a reason to set the medication aside and contact the pharmacy. The absence of those changes is not proof that an overheated or frozen product remains usable. A useful temperature-excursion report includes how long the item was out, the warmest or coldest likely temperature and whether it froze.
Whether a temperature-exposed medication remains usable is a decision for the dispensing pharmacist and prescriber with the patient, not a calculation to make at home. At Promise, a licensed provider reviews every request, and not everyone qualifies.